Mackenzie Financial Corp Ocular Therapeutix, Inc Call Options Transaction History
Mackenzie Financial Corp
- $71.6 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OCUL
# of Institutions
205Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$171 Million4.71% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$166 Million98.75% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$152 Million23.46% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$138 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$100 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $919M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...